Ma D - Search Results

1

Pyridinylquinazolines selectively inhibit human methionine aminopeptidase-1 in cells.

Zhang F, Bhat S, Gabelli SB, Chen X, Miller MS, Nacev BA, Cheng YL, Meyers DJ, Tenney K, Shim JS, Crews P, Amzel LM, Ma D, Liu JO. Zhang F, et al. Among authors: ma d. J Med Chem. 2013 May 23;56(10):3996-4016. doi: 10.1021/jm400227z. Epub 2013 May 1. J Med Chem. 2013. PMID: 23634668 Free PMC article.

2

Total synthesis of the cyclodepsipeptide apratoxin A and its analogues and assessment of their biological activities.

Ma D, Zou B, Cai G, Hu X, Liu JO. Ma D, et al. Chemistry. 2006 Oct 10;12(29):7615-26. doi: 10.1002/chem.200600599. Chemistry. 2006. PMID: 16832801

3

Synthesis and antitumor activity of cyclodepsipeptide zygosporamide and its analogues.

Wang Y, Zhang F, Zhang Y, Liu JO, Ma D. Wang Y, et al. Among authors: ma d. Bioorg Med Chem Lett. 2008 Aug 1;18(15):4385-7. doi: 10.1016/j.bmcl.2008.06.066. Epub 2008 Jun 21. Bioorg Med Chem Lett. 2008. PMID: 18606540

4

Pyridinylpyrimidines selectively inhibit human methionine aminopeptidase-1.

Zhang P, Yang X, Zhang F, Gabelli SB, Wang R, Zhang Y, Bhat S, Chen X, Furlani M, Amzel LM, Liu JO, Ma D. Zhang P, et al. Among authors: ma d. Bioorg Med Chem. 2013 May 1;21(9):2600-17. doi: 10.1016/j.bmc.2013.02.023. Epub 2013 Feb 21. Bioorg Med Chem. 2013. PMID: 23507151 Free PMC article.

5

Identification, biochemical and structural evaluation of species-specific inhibitors against type I methionine aminopeptidases.

Kishor C, Arya T, Reddi R, Chen X, Saddanapu V, Marapaka AK, Gumpena R, Ma D, Liu JO, Addlagatta A. Kishor C, et al. Among authors: ma d. J Med Chem. 2013 Jul 11;56(13):5295-305. doi: 10.1021/jm400395p. Epub 2013 Jun 27. J Med Chem. 2013. PMID: 23767698

6

Design and Synthesis of Novel Macrocyclic Derivatives as Potent and Selective Cyclin-Dependent Kinase 7 Inhibitors.

Niu P, Tao Y, Lin G, Xu H, Meng Q, Yang K, Huang W, Song M, Ding K, Ma D, Fan M. Niu P, et al. Among authors: ma d. J Med Chem. 2024 Apr 25;67(8):6099-6118. doi: 10.1021/acs.jmedchem.3c01832. Epub 2024 Apr 8. J Med Chem. 2024. PMID: 38586950

7

Discovery of LHQ490 as a highly selective fibroblast growth factor receptor 2 (FGFR2) inhibitor.

Li H, Ke R, Zhou Y, Chang S, Wang J, Su C, Wu P, Yang B, Wang Z, Ding K, Ma D. Li H, et al. Among authors: ma d. Eur J Med Chem. 2024 Jun 5;272:116473. doi: 10.1016/j.ejmech.2024.116473. Epub 2024 May 4. Eur J Med Chem. 2024. PMID: 38718625

8

Discovery and optimization of thieno[3,2-d]pyrimidine derivatives as highly selective inhibitors of cyclin-dependent kinase 7.

Zhang H, Lin G, Jia S, Zhang Y, Wu J, Tao Y, Huang W, Song M, Ding K, Ma D, Fan M. Zhang H, et al. Among authors: ma d. Eur J Med Chem. 2024 Jan 5;263:115955. doi: 10.1016/j.ejmech.2023.115955. Epub 2023 Nov 17. Eur J Med Chem. 2024. PMID: 38000213

9

Discovery of novel macrocyclic derivatives as potent and selective cyclin-dependent kinase 2 inhibitors.

Niu P, Tao Y, Meng Q, Huang Y, Li S, Ding K, Ma D, Ye Z, Fan M. Niu P, et al. Among authors: ma d. Bioorg Med Chem. 2024 Apr 15;104:117711. doi: 10.1016/j.bmc.2024.117711. Epub 2024 Apr 3. Bioorg Med Chem. 2024. PMID: 38583237

10

Studies on the structure-activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 1: Tuning the N-substituents.

Ben L, Jones ED, Zhou E, Li C, Baylis DC, Yu S, Wang M, He X, Coates JA, Rhodes DI, Pei G, Deadman JJ, Xie X, Ma D. Ben L, et al. Among authors: ma d. Bioorg Med Chem Lett. 2010 Jul 15;20(14):4012-4. doi: 10.1016/j.bmcl.2010.05.102. Epub 2010 Jun 1. Bioorg Med Chem Lett. 2010. PMID: 20561788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,757 results

Search Page

Filters